Search research articles
Contact Us
Filters
Showing results (81-90 of 132) with videos related to
Page
of 14
Sort By:
Human Pathology
|
November 18, 2023
HER2 categorical changes after neoadjuvant chemotherapy: A study of 192 matched breast cancers with the inclusion of HER2-Low category
Cansu Karakas, Haley Tyburski, Bradley M Turner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 2, 2015
Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score
Bradley M Turner, Kristin A Skinner, Ping Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2005
The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course
Brian J Yoder, Elisa Tso, Marek Skacel, et al.
Archives of Pathology & Laboratory Medicine
|
April 4, 2023
Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression
Gary Tozbikian, Savitri Krishnamurthy, Marilyn M Bui, et al.
Cancer Medicine
|
June 15, 2019
Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX<sup>®</sup> recurrence score <26
Bradley M Turner, Mary Ann Gimenez-Sanders, Armen Soukiazian, et al.
Archives of Pathology & Laboratory Medicine
|
November 19, 2013
Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast
Patrick L Fitzgibbons, Deborah A Dillon, Randa Alsabeh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 5, 2011
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma
Yingchuan Hu, Santhoshi Bandla, Tony E Godfrey, et al.
Journal of the National Cancer Institute
|
October 24, 2012
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues
Veronique M Neumeister, Valsamo Anagnostou, Summar Siddiqui, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 25, 2014
Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time
Maria Vassilakopoulou, Fabio Parisi, Summar Siddiqui, et al.
Human Pathology
|
May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study
David G Hicks, Brian J Yoder, James Pettay, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 132) with videos related to
Sort By:
Page
of 14
Human Pathology
|
November 18, 2023
HER2 categorical changes after neoadjuvant chemotherapy: A study of 192 matched breast cancers with the inclusion of HER2-Low category
Cansu Karakas, Haley Tyburski, Bradley M Turner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 2, 2015
Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score
Bradley M Turner, Kristin A Skinner, Ping Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2005
The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course
Brian J Yoder, Elisa Tso, Marek Skacel, et al.
Archives of Pathology & Laboratory Medicine
|
April 4, 2023
Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression
Gary Tozbikian, Savitri Krishnamurthy, Marilyn M Bui, et al.
Cancer Medicine
|
June 15, 2019
Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX<sup>®</sup> recurrence score <26
Bradley M Turner, Mary Ann Gimenez-Sanders, Armen Soukiazian, et al.
Archives of Pathology & Laboratory Medicine
|
November 19, 2013
Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast
Patrick L Fitzgibbons, Deborah A Dillon, Randa Alsabeh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 5, 2011
HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma
Yingchuan Hu, Santhoshi Bandla, Tony E Godfrey, et al.
Journal of the National Cancer Institute
|
October 24, 2012
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues
Veronique M Neumeister, Valsamo Anagnostou, Summar Siddiqui, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 25, 2014
Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time
Maria Vassilakopoulou, Fabio Parisi, Summar Siddiqui, et al.
Human Pathology
|
May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study
David G Hicks, Brian J Yoder, James Pettay, et al.
Page
of 14